{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:32:53Z","timestamp":1793305973254,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01DK123093"],"award-info":[{"award-number":["5R01DK123093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jlr.2026.101142","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:44:17Z","timestamp":1788331457000},"page":"101142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A humanized mouse model of APOB deficiency recapitulates hypobetalipoproteinemia"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-7393","authenticated-orcid":false,"given":"Amita","family":"Tiyaboonchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-1898","authenticated-orcid":false,"given":"Anne","family":"Vonada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5205-8261","authenticated-orcid":false,"given":"Jeffrey","family":"Posey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-6666","authenticated-orcid":false,"given":"Kevin L.","family":"Keys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-880X","authenticated-orcid":false,"given":"Carl","family":"Pelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0451-9267","authenticated-orcid":false,"given":"Xiping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Grompe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2026.101142_bib1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1194\/jlr.M300508-JLR200","article-title":"Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity","volume":"45","author":"Tanoli","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.101142_bib2","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1073\/pnas.90.6.2389","article-title":"Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice","volume":"90","author":"Homanics","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2026.101142_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpb.b15-00716","article-title":"Metabolism and modification of apolipoprotein B-Containing lipoproteins involved in dyslipidemia and atherosclerosis","volume":"39","author":"Morita","year":"2016","journal-title":"Biol. Pharm. Bull"},{"key":"10.1016\/j.jlr.2026.101142_bib4","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1373\/clinchem.2004.038026","article-title":"Lipid disorders and mutations in the APOB gene","volume":"50","author":"Whitfield","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jlr.2026.101142_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2008.09.021","article-title":"Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia","volume":"399","author":"Katsuda","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jlr.2026.101142_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1194\/jlr.M200342-JLR200","article-title":"Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis","volume":"44","author":"Schonfeld","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.101142_bib7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/lt.21766","article-title":"Recurrent familial hypobetalipoproteinemia-induced nonalcoholic fatty liver disease after living donor liver transplantation","volume":"15","author":"Harada","year":"2009","journal-title":"Liver Transpl."},{"key":"10.1016\/j.jlr.2026.101142_bib8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(96)70082-3","article-title":"Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B","volume":"111","author":"Tarugi","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2026.101142_bib9","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1038\/s41598-019-39998-2","article-title":"Rare pathogenic variants predispose to hepatocellular carcinoma in Nonalcoholic Fatty liver disease","volume":"9","author":"Pelusi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2026.101142_bib10","first-page":"1","article-title":"Clinical significance of APOB inactivation in hepatocellular carcinoma","volume":"50","author":"Lee","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jlr.2026.101142_bib11","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.3748\/wjg.v20.i36.12945","article-title":"Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors","volume":"20","author":"Dongiovanni","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jlr.2026.101142_bib12","doi-asserted-by":"crossref","first-page":"32807","DOI":"10.1074\/jbc.M004913200","article-title":"A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides","volume":"275","author":"Chen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2026.101142_bib13","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1073\/pnas.93.13.6393","article-title":"Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100","volume":"93","author":"Farese","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2026.101142_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fcvm.2019.00046","article-title":"Mouse models for atherosclerosis research-which is my line?","volume":"6","author":"Oppi","year":"2019","journal-title":"Front Cardiovasc. Med."},{"key":"10.1016\/j.jlr.2026.101142_bib15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbrc.2020.01.067","article-title":"A mouse model of humanized liver shows a human-like lipid profile, but does not form atherosclerotic plaque after western type diet","volume":"524","author":"Sari","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jlr.2026.101142_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078550","article-title":"Mice with chimeric livers are an improved model for human lipoprotein metabolism","volume":"8","author":"Ellis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2026.101142_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.31052","article-title":"Insights from liver-humanized mice on cholesterol Lipoprotein metabolism and LXR-Agonist pharmacodynamics in humans","volume":"72","author":"Minniti","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2026.101142_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111321","article-title":"Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice","volume":"40","author":"Kabbani","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2026.101142_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcmgh.2017.07.002","article-title":"Analysis of hepatitis C virus particle heterogeneity in Immunodeficient Human liver chimeric fah-\/- mice","volume":"4","author":"Andreo","year":"2017","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2026.101142_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/humu.1380020205","article-title":"Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I","volume":"2","author":"Grompe","year":"1993","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jlr.2026.101142_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM199408113310603","article-title":"A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I","volume":"331","author":"Grompe","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jlr.2026.101142_bib22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jlr.2026.101142_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.scr.2013.03.002","article-title":"New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants","volume":"11","author":"Gramignoli","year":"2013","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.jlr.2026.101142_bib24","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.transproceed.2006.02.149","article-title":"Development of humanized mice for the study of hepatitis C virus infection","volume":"38","author":"Turrini","year":"2006","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.jlr.2026.101142_bib25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.scr.2014.08.006","article-title":"Extensive double humanization of both liver and hematopoiesis in FRGN mice","volume":"13","author":"Wilson","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.jlr.2026.101142_bib26","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.ymthe.2021.01.024","article-title":"Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes","volume":"29","author":"Zabulica","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jlr.2026.101142_bib27","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.gastro.2015.05.043","article-title":"Fibroblast growth factor signaling controls liver size in mice with humanized livers","volume":"149","author":"Naugler","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2026.101142_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf2982","article-title":"Mice with humanized livers reveal the role of hepatocyte clocks in rhythmic behavior","volume":"9","author":"Delb\u00e8s","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jlr.2026.101142_bib29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ymthe.2020.10.018","article-title":"Liver injury increases the incidence of HCC following AAV gene therapy in mice","volume":"29","author":"Dalwadi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jlr.2026.101142_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-018-0068-2","article-title":"A Plasmodium berghei sporozoite-based vaccination platform against human malaria","volume":"3","author":"Mendes","year":"2018","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.jlr.2026.101142_bib31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.4512","article-title":"A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","author":"Kisalu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2026.101142_bib32","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2026.101142_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virol.2016.12.017","article-title":"Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection","volume":"502","author":"Winer","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.jlr.2026.101142_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nmeth.3432","article-title":"Plasmodium falciparum genetic crosses in a humanized mouse model","volume":"12","author":"Vaughan","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jlr.2026.101142_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92587","article-title":"Assessing drug efficacy against Plasmodium falciparum liver stages in vivo","volume":"3","author":"Flannery","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jlr.2026.101142_bib36","series-title":"nf-core\/rnaseq: nf-core\/rnaseq v3.18.0 - Lithium Lynx (Zenodo)","author":"Patel","year":"2024"},{"key":"10.1016\/j.jlr.2026.101142_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jlr.2026.101142_bib38","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1093\/bioinformatics\/btx192","article-title":"BioContainers: an open-source and community-driven framework for software standardization","volume":"33","author":"da Veiga Leprevost","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jlr.2026.101142_bib39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nbt.3820","article-title":"Nextflow enables reproducible computational workflows","volume":"35","author":"Di Tommaso","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jlr.2026.101142_bib40","series-title":"BBMap: A Fast, Accurate, Splice-Aware Aligner","author":"Bushnell","year":"2014"},{"key":"10.1016\/j.jlr.2026.101142_bib41","series-title":"FastQC: A Quality Control Tool for High Throughput Sequence Data","author":"Andrews","year":"2010"},{"key":"10.1016\/j.jlr.2026.101142_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jlr.2026.101142_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.jlr.2026.101142_bib44","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jlr.2026.101142_bib45","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.jlr.2026.101142_bib46","series-title":"R: A language and environment for statistical computing","author":"Team","year":"2021"},{"key":"10.1016\/j.jlr.2026.101142_bib47","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.jlr.2026.101142_bib48","doi-asserted-by":"crossref","first-page":"20616","DOI":"10.1016\/S0021-9258(17)30547-1","article-title":"Apolipoprotein B messenger RNA editing is developmentally regulated and widely expressed in human tissues","volume":"265","author":"Teng","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2026.101142_bib49","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0022-2275(20)41333-1","article-title":"Developmental and age-related changes in apolipoprotein B mRNA editing in mice","volume":"33","author":"Higuchi","year":"1992","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.101142_bib50","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0022-2275(20)36966-2","article-title":"Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins","volume":"34","author":"Greeve","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.101142_bib51","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1053\/jhep.2002.32527","article-title":"Apolipoprotein synthesis in nonalcoholic steatohepatitis","volume":"35","author":"Charlton","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2026.101142_bib52","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1194\/jlr.E005140","article-title":"Does inhibition of apolipoprotein B synthesis produce foie gras?","volume":"51","author":"Feingold","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.101142_bib53","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.M012872","article-title":"siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids","volume":"52","author":"Tadin-Strapps","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.101142_bib54","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1172\/JCI86028","article-title":"Inhibition of apolipoprotein B synthesis stimulates endoplasmic reticulum autophagy that prevents steatosis","volume":"126","author":"Conlon","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2026.101142_bib55","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1242\/jcs.01131","article-title":"LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation","volume":"117","author":"Kabeya","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jlr.2026.101142_bib56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2015.05.044","article-title":"Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia","volume":"88","author":"Burnett","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jlr.2026.101142_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084281","article-title":"APOB CRISPR-Cas9 engineering in hypobetalipoproteinemia: a promising tool for functional studies of novel variants","volume":"23","author":"Vanhoye","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2026.101142_bib58","article-title":"Liver Fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment","volume":"8","author":"Heyens","year":"2021","journal-title":"Front Med. (Lausanne)"},{"key":"10.1016\/j.jlr.2026.101142_bib59","series-title":"Endotext","article-title":"Introduction to lipids and lipoproteins","author":"Feingold","year":"2000"},{"key":"10.1016\/j.jlr.2026.101142_bib60","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1194\/jlr.M400492-JLR200","article-title":"An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis","volume":"46","author":"Crooke","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.101142_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100867","article-title":"Human hepatoma Huh-7 cell culture models deficient in apolipoprotein B secretion","volume":"66","author":"Valmiki","year":"2025","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.101142_bib62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2125.2012.04469.x","article-title":"Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B","volume":"76","author":"Crooke","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jlr.2026.101142_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/VHRM.S191965","article-title":"Mipomersen in familial hypercholesterolemia: an update on health-related quality of life and patient-reported outcomes","volume":"18","author":"Chambergo-Michilot","year":"2022","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.jlr.2026.101142_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1517\/13543784.2011.547471","article-title":"Mipomersen, an antisense apolipoprotein B synthesis inhibitor","volume":"20","author":"Bell","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jlr.2026.101142_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jlr.2026.101142_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/14656566.2018.1550071","article-title":"Mipomersen and its use in familial hypercholesterolemia","volume":"20","author":"Parham","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jlr.2026.101142_bib67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/apha.12253","article-title":"The effects of equal caloric high fat and western diet on metabolic syndrome, oxidative stress and vascular endothelial function in mice","volume":"211","author":"Heinonen","year":"2014","journal-title":"Acta Physiol. (Oxf)"},{"key":"10.1016\/j.jlr.2026.101142_bib68","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2164-13-84","article-title":"C57Bl\/6 N mice on a western diet display reduced intestinal and hepatic cholesterol levels despite a plasma hypercholesterolemia","volume":"13","author":"Desmarchelier","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jlr.2026.101142_bib69","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200346R","article-title":"A new preclinical model of western diet-induced progression of non-alcoholic steatohepatitis to hepatocellular carcinoma","volume":"36","author":"Green","year":"2022","journal-title":"Faseb j"},{"key":"10.1016\/j.jlr.2026.101142_bib70","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000434","article-title":"An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD","volume":"8","author":"Zhang","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jlr.2026.101142_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/biom14040476","article-title":"Innate immunity and MASLD","volume":"14","author":"Meyer","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jlr.2026.101142_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186424","article-title":"Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatment","volume":"135","author":"Chen","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2026.101142_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102813","article-title":"Enhancement of therapeutic transgene insertion for treatment of murine phenylketonuria","volume":"37","author":"Martinez","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jlr.2026.101142_bib74","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B gene therapy with a high-specific-activity factor IX variant","volume":"377","author":"George","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jlr.2026.101142_bib75","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/HEP.0000000000000631","article-title":"Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation","volume":"79","author":"Vonada","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2026.101142_bib76","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI118269","article-title":"Apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and Apo A-I transport rates in heterozygotes","volume":"96","author":"Huang","year":"1995","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227526001720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227526001720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:20:21Z","timestamp":1793305221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227526001720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0022227526001720"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2026.101142","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A humanized mouse model of APOB deficiency recapitulates hypobetalipoproteinemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2026.101142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"101142"}}